Get started
MarketMoversReport

MediWound Announces Positive Results from Its U.S. Phase 2 Trial

Long
MediWound Ltd. (NASDAQ:MDWD)  
MarketMoversReport  
NASDAQ:MDWD   MediWound Ltd.
Beyond Technical Analysis
0
0
beyondta
MDWD: MediWound Ltd.
2022-05-12 07:00:00
MediWound Announces Positive Results from Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.